Interleukin 4 (IL-4) is a cytokine known to be important in promoting the survival of CLL cells in-vitro at concentrations between 1 and 25 ng/mL as well as in-vivo, and may be an important factor in resistance to therapy (8-11). Here, IL4 is linked to B-cell chronic lymphocytic leukemia.